Recursion Announces Completion of NVIDIA-Powered BioHive-2, the Largest Supercomputer in Pharmaceutical Industry - Seite 2
A smaller model similar to Phenom-1, called Phenom-Beta, has been released for external use on the NVIDIA BioNeMo platform. The Phenom series is just one of several different models Recursion has developed to accelerate the drug discovery process using biological, chemical, and real-world patient data. Phenom-Beta is the first third-party model to be made available on the BioNeMo platform.
“Accelerated computing, combined with the power of generative AI, is propelling the pharmaceutical industry into a new, advanced era of drug discovery,” said Rory Kelleher, global head of business development for life sciences at NVIDIA. “BioHive-2, powered by NVIDIA DGX AI supercomputing, is poised to accelerate the development of additional industry-leading foundation models across biology, chemistry, and healthcare.”
Other achievements that relied on Recursion’s platform, powered by NVIDIA accelerated computing, include the massive protein-ligand interaction prediction dataset announced last year. Recursion predicted the protein target(s) for approximately 36 billion chemical compounds in the Enamine REAL Space. As a result of this significant computational accomplishment, Recursion and Enamine have formed a collaboration to generate enriched compound libraries for the global drug discovery industry.
Lesen Sie auch
About Recursion
Recursion is a
clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that
continuously expands one of the world’s largest proprietary biological, chemical and patient-centric datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its
dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab
experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology, chemistry and
patient-centric data to advance the future of medicine.